Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and NeckJay S. Cooper, Karen K. Fu, Thomas F. Pajak et al.|New England Journal of Medicine|2004Cited by 3.2k
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Jacques Bernier, Jean Louis Lefèbvre, Jay S. Cooper et al.|Head & Neck|2005Cited by 1.8k
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid CancerRazelle Kurzrock, Ravi Salgia, David S. Hong et al.|Journal of Clinical Oncology|2011Cited by 551
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal CancerDavid G. Pfister, Gregory T. Wolf, Scott A. Laurie et al.|Journal of Clinical Oncology|2006Cited by 504
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateArlene A. Forastiere, Gregory T. Wolf, Nofisat Ismaila et al.|Journal of Clinical Oncology|2017Cited by 366